Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VADIM FINKIELSTEIN

NPI
1336188481
CMS profile
1292609
Location
PRINCETON JUNCTION, NJ

General Payments · PY2018–2024

$156,390.30

  • Reported across 311 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$9,777.59

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $20,907.25 46
PY2019 $27,573.37 70
PY2020 $14,169.56 45
PY2021 $28,599.68 30
PY2022 $33,166.99 49
PY2023 $22,195.86 43
PY2024 $9,777.59 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $16.86 06/04/2024 Food and Beverage Undisputed 01/23/2026 1117553539 CMS
Amgen Inc. $96.69 08/13/2024 Food and Beverage Undisputed 01/23/2026 1117553541 CMS
Amgen Inc. $16.11 12/10/2024 Food and Beverage Undisputed 01/23/2026 1117553543 CMS
AstraZeneca Pharmaceuticals LP $18.89 09/10/2024 Food and Beverage Undisputed 01/23/2026 1110553466 CMS
Aurinia Pharma U.S., Inc. $17.86 04/25/2024 Food and Beverage Undisputed 01/23/2026 1150680131 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.61 01/25/2024 Food and Beverage Undisputed 01/23/2026 1086216335 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.92 03/29/2024 Food and Beverage Undisputed 01/23/2026 1086159322 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.51 10/01/2024 Food and Beverage Undisputed 01/23/2026 1086106998 CMS
CALLIDITAS THERAPEUTICS US INC. $17.00 06/18/2024 Food and Beverage Undisputed 01/23/2026 1141517151 CMS
GlaxoSmithKline, LLC. $14.55 01/05/2024 Food and Beverage Undisputed 01/23/2026 1116606002 CMS
GlaxoSmithKline, LLC. $16.98 03/13/2024 Food and Beverage Undisputed 01/23/2026 1115909602 CMS
GlaxoSmithKline, LLC. $15.11 06/13/2024 Food and Beverage Undisputed 01/23/2026 1116022826 CMS
Lilly USA, LLC $16.52 03/20/2024 Food and Beverage Undisputed 01/23/2026 1135462805 CMS
Novartis Pharmaceuticals Corporation $17.50 05/14/2024 Food and Beverage Undisputed 01/23/2026 1086959825 CMS
Novo Nordisk Inc $18.65 05/31/2024 Food and Beverage Undisputed 01/23/2026 1108576615 CMS
Novo Nordisk Inc $23.24 08/22/2024 Food and Beverage Undisputed 01/23/2026 1108578567 CMS
Otsuka America Pharmaceutical, Inc. $125.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 1118892734 CMS
Otsuka America Pharmaceutical, Inc. $2,522.00 03/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118892736 CMS
Otsuka America Pharmaceutical, Inc. $58.96 03/20/2024 Travel and Lodging Undisputed 01/23/2026 1118892738 CMS
Otsuka America Pharmaceutical, Inc. $69.64 03/25/2024 Food and Beverage Undisputed 01/23/2026 1118892740 CMS
Otsuka America Pharmaceutical, Inc. $2,522.00 03/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118892742 CMS
Otsuka America Pharmaceutical, Inc. $91.12 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1118892744 CMS
Otsuka America Pharmaceutical, Inc. $9.94 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1118892746 CMS
Otsuka America Pharmaceutical, Inc. $822.00 04/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118892748 CMS
Otsuka America Pharmaceutical, Inc. $1,455.00 04/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118892750 CMS
Otsuka America Pharmaceutical, Inc. $1,455.00 04/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118892752 CMS
Otsuka America Pharmaceutical, Inc. $274.00 05/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118892754 CMS
Otsuka America Pharmaceutical, Inc. $20.93 10/08/2024 Food and Beverage Undisputed 01/23/2026 1118892756 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.